Literature DB >> 8400264

In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue.

J C Reubi1, B Waser, U Horisberger, E Krenning, S W Lamberts, J O Gebbers, P Gersbach, J A Laissue.   

Abstract

Receptors for the neuropeptide somatostatin (SS) were evaluated in vitro and in vivo in various human lymphatic tissues, ie, thymus, spleen, and lymph nodes; thymic carcinoids and thymomas were also tested. The receptors were measured in vitro using receptor autoradiography on tissue sections incubated with the SS analog 125I-[Tyr3]-octreotide or 125I-[Leu8,D-Trp22,Tyr25]-SS-28. All tissues were SS-receptor positive for either radioligand, except the thymomas. In thymic tissue, the receptors were diffusely located in the medulla, presumably on epithelial cells. In the spleen, the red pulp was strongly labeled. In the lymph nodes, the germinal centers were preferentially labeled. In all tissues, the receptors were of high affinity (kd thymus, 0.84 nmol/L; kd spleen, 1.6 nmol/L; kd lymph node, 0.62 nmol/L) and specific for SS. Displacement by nanomolar concentrations of SS-14, SS-28, and octreotide was observed, as was guanosine triphosphate dependency. The in vivo visualization of somatostatin receptors was performed after injection of 111In-DTPA-octreotide and gamma-camera scintigraphy. The spleen, but not thymus or lymph nodes, were visualized. These data suggest an important role for SS in regulating immune functions through SS receptors in thymus, spleen, and lymph nodes. Furthermore, SS may regulate neuroendocrine functions in the thymus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400264

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  The therapeutic value of somatostatin and its analogues.

Authors:  S Farooqi; J S Bevan; M C Sheppard; J A Wass
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 2.  Somatostatin receptor scintigraphy in thoracic diseases.

Authors:  P Ameri; F Gatto; M Arvigo; G Villa; E Resmini; F Minuto; G Murialdo; D Ferone
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

3.  Early massive accumulation of In-111 pentetreotide in a metastatic liver tumor of islet cell carcinoma.

Authors:  E Tsukamoto; K Kanegae; K Itoh; S Okushiba; K Ohno; H Katoh; N Tamaki
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

4.  Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphy.

Authors:  D Ferone; R Pivonello; D J Kwekkeboom; F Gatto; P Ameri; A Colao; R R de Krijger; F Minuto; S W J Lamberts; P M van Hagen; L J Hofland
Journal:  J Endocrinol Invest       Date:  2011-07-13       Impact factor: 4.256

Review 5.  The diagnostic utility of somatostatin receptor scintigraphy in oncology.

Authors:  R Valkema; J Steens; F J Cleton; E K Pauwels
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  "Peptabody": a new type of high avidity binding protein.

Authors:  A V Terskikh; J M Le Doussal; R Crameri; I Fisch; J P Mach; A V Kajava
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features.

Authors:  D Ferone; D J Kwekkeboom; R Pivonello; A Bogers ADColao; S W Lamberts; P M van Hagen; L J Hofland
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

Review 8.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

Review 9.  Somatostatin and somatostatin receptor physiology.

Authors:  Philip Barnett
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

10.  Treatment and prevention of lymphorrhea after radical gastrectomy of gastric cancer.

Authors:  Lin Sheng-Zhang; Tong Hong-Fei; Ni Zhong-Lin; Yu Yao-Jun; You Tao; Zhang Wei
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-10       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.